ascent: sacituzumab govitecan biomarker analysis
Published 3 years ago • 382 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
4:25
ascent: sacituzumab govitecan shows promise in mtnbc patients
-
1:08
ascent-05: sacituzumab govitecan and pembrolizumab in tnbc
-
1:34
sacituzumab govitecan effective for hr metastatic breast cancer regardless of trop-2 status
-
1:49
final os analysis of sacituzumab govitecan in tropics-02
-
3:54
biomarker analysis: sacituzumab govitecan vs chemotherapy in metastatic tpn breast cancer
-
14:02
approval of capivasertib for pik3ca/akt1/pten–altered breast cancer: jason mouabbi and carlos doti
-
22:00
bree stilwell advocated for herself to heal her stage 4 metastatic breast cancer
-
5:57
antibody drug conjugates: characterization
-
3:10
ascent trial: sacituzumab govitecan for tnbc
-
1:58
ascent-04: sacituzumab govitecan and pembrolizumab in pd-l1-positive tnbc
-
5:24
biomarker data point to wide use of sacituzumab govitecan in advanced tnbc | sara hurvitz
-
1:36
real-word efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer
-
2:01
ascent: sacituzumab govitecan outperforms chemo in black patients with tnbc
-
2:16
efficacy of sacituzumab govitecan by trop-2 expression in patients with muc
-
3:31
the ascent of sacituzumab govitecan in metastatic tnbc | aditya bardia
-
0:46
oncotarget: sacituzumab govitecan in triple-negative breast cancer
-
2:57
efficacy of sacituzumab govitecan in muc by trop-2 expression
-
3:05
esmo 2020 highlights on sacituzumab govitecan in metastatic tnbc: the ascent study
-
3:47
sacituzumab govitecan in mtnbc
-
3:59
sacituzumab govitecan for treatment-refractory metastatic breast cancer
-
1:29
aditya bardia, md, mph, discusses the design of newly approved sacituzumab govitecan
-
5:07
tropics-02: sacituzumab govetican improves pfs versus physicians choice for hr /her2- mbc